Skip to main content

Table 2 Original diagnosis and revised diagnosis after expert revision and immunohistochemistry

From: Distinct pattern of lymphoid neoplasms characterizations according to the WHO classification (2016) and prevalence of associated Epstein–Barr virus infection in Nigeria population

ORIGINAL DIAGNOSIS
  BL
n = 2
CLL
n = 5
AITL
n = 2
DLBCL
n = 12
HL/HD
n = 6
PCM
n = 1
Reactive
n = 15
Carcinoma
n = 1
FL
n = 1
NK lymphoma
n = 1
LPL
n = 1
MALT
n = 2
NHL
n = 53
REVISED DIAGONSIS
CLL
n = 23
1 4 1 1 16
HL
n = 17
1 1 5 2 8
DLBCL
n = 14
1 4 1 1 7
BL
n = 5
2 1 2
SMZL
n = 2
2
ENMZL
n = 1
1
B-LBL
n = 1
1
AITL
n = 1
1
FL
n = 1
1
LPL
n = 1
1
Sarcoma
n = 4
4
Metastasis
n = 6
1 1 1 3
CD
n = 2
1 1
RDD
n = 2
2
Reactive
n = 22
1 10 1 10
  1. AITL Angioimmunoblastic T-cell lymphoma, BL Burkitt lymphoma, B-LBL B-lymphoblastic leukaemia/lymphoma, CD Castleman disease, CLL chronic lymphocytic leukemia, DLBCL diffuse large B-cell lymphomas, ENMZL extranodal marginal zone lymphoma, FL follicular lymphoma, HL Hodgkin lymphoma, HD Hodgkin disease, LPL lymphoplasmacytic lymphoma, NHL non-Hodgkin lymphomas, PCM plasmacytoma, RDD Rosai-Dorfman disease, SMZL splenic marginal zone lymphoma